ArticleEuropean heart journal. Case reports2024
Cardiac resynchronization therapy by pacing the right ventricular dorsal site of inflow and anterior outflow for congenitally corrected transposition of the great arteries: a case report.
Article in European heart journal. Case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Evidence regarding cardiac resynchronization therapy (CRT) for congenitally corrected transposition of the great arteries (ccTGA) is insufficient. The timing to perform CRT and optimal pacing sites have not been systematically studied. We performed CRT for ccTGA with a complete atrioventricular block (CAVB) by pacing the dorsal site of right ventricular inflow (dRVI) and anterior RV outflow tract (aRVOT). Case summary: We examined a man aged 19 with ccTGA (S.L.L) and Ebstein anomaly, who developed CAVB at 19. We decided to implant CRT rather than a conventional pacemaker for preventing right ventricular (RV) dysfunction. At first, we implanted transvenous pacing leads on the right atrium and dRVI via the coronary sinus. During dRVI pacing, the most delayed contraction site was the aRVOT by the echocardiographic speckle tracking and the electrophysiological study. Accordingly, we implanted additional epicardial lead in the aRVOT and completed the implantation of CRT. After the CRT, the QRS duration was shortened from 187 to 132 ms and RV ejection fraction (RVEF) by right ventriculography increased from 35% to 42%.The distance between two ventricular leads (dRVI and aRVOT) was 93% with 85% of longitudinal and radial direction in the RV. The effective CRT in this case was characterized by covering RV in the longitudinal and radial direction. Conclusion: Separate two-point pacing on the dRVI and aRVOT, which assists the contraction in the longitudinal and radial dimension, is considered a potential position for CRT pacing and an effective method in ccTGA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.